These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22568045)

  • 21. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
    Thenmozhi K; Yoo YJ
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solubilization and interaction of sulindac with polyvinylpyrrolidone K30 in the solid state and in aqueous solution.
    Tros de Ilarduya MC; Martín C; Goñi MM; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 1998 Mar; 24(3):295-300. PubMed ID: 9876588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on formulation development of mouth dissolving tablets of Carvedilol.
    Pokharkar V; Dhar S; Mandpe L
    Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):21-8. PubMed ID: 19957540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro dissolution and physicochemical characterizations of novel PVP-based solid dispersions containing valsartan prepared by a freeze-drying method.
    Xu WJ; Liu Y; Shi LL; Cui JH; Cao QR
    Pak J Pharm Sci; 2014 Nov; 27(6):1799-804. PubMed ID: 25362604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of novel interpenetrating network gellan gum-poly(vinyl alcohol) hydrogel microspheres for the controlled release of carvedilol.
    Agnihotri SA; Aminabhavi TM
    Drug Dev Ind Pharm; 2005 Jul; 31(6):491-503. PubMed ID: 16109622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of miscibility analysis and determination of Soluplus solubility map for development of carvedilol-loaded nanofibers.
    Kaljević O; Djuris J; Čalija B; Lavrič Z; Kristl J; Ibrić S
    Int J Pharm; 2017 Nov; 533(2):445-454. PubMed ID: 28495583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
    Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery.
    Patil SB; Sawant KK
    J Microencapsul; 2009 Aug; 26(5):432-43. PubMed ID: 18932060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
    Ruan LP; Yu BY; Fu GM; Zhu DN
    J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
    Sammour OA; Hammad MA; Megrab NA; Zidan AS
    AAPS PharmSciTech; 2006 Jun; 7(2):E55. PubMed ID: 16796372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and physicochemical characterization of binary and ternary ground mixtures of carvedilol with PVP and SLS aimed to improve the drug dissolution.
    Bolourchian N; Talamkhani Z; Nokhodchi A
    Pharm Dev Technol; 2019 Nov; 24(9):1115-1124. PubMed ID: 31282827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissolution kinetics for coprecipitates of diflunisal with PVP K30.
    Rodríguez-Espinosa C; Martínez-Ohárriz MC; Martín C; Goñi MM; Vélaz I; Sánchez M
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):109-12. PubMed ID: 9725466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions.
    Ingkatawornwong S; Kaewnopparat N; Tantishaiyakul V
    Pharmazie; 2001 Mar; 56(3):227-30. PubMed ID: 11265589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation.
    Liu D; Yu S; Zhu Z; Lyu C; Bai C; Ge H; Yang X; Pan W
    Int J Pharm; 2014 Nov; 475(1-2):496-503. PubMed ID: 25219321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical Salts of Carvedilol: Polymorphism and Physicochemical Properties.
    Hiendrawan S; Widjojokusumo E; Veriansyah B; Tjandrawinata RR
    AAPS PharmSciTech; 2017 May; 18(4):1417-1425. PubMed ID: 27600325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid.
    Yuvaraja K; Khanam J
    J Pharm Biomed Anal; 2014 Aug; 96():10-20. PubMed ID: 24705456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.